Key Insights

Highlights

Treatment Research

6 treatments under study, led by Graded Glucose Infusion With Gip Alone

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Withdrawn1

Clinical Trials (1)

Showing 1 of 1 trials
NCT01951716Phase 1WithdrawnPrimary

Effects of Xenin-25 on Insulin Secretion and Gastric Emptying in Humans With and Without a Complete Truncal Vagotomy

Showing all 1 trials

Research Network

Common Treatments

  • Graded Glucose Infusion With Gip Alone1
  • Graded Glucose Infusion With Xenin25 Alone1
  • Meal Tolerance Test With Xenin251
  • Graded Glucose Infusion With Gip Plus Xenin251
  • Graded Glucose Infusion With Placebo1

Active Sponsors

  • American Diabetes Association1
  • Washington University School of Medicine1

Top Investigators

Activity Timeline